Reata Pharmaceuticals, Inc.

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson 6.79%131.520.7%$2065.55m
PFEPfizer Inc. 3.04%31.840.9%$1475.40m
MRKMerck & Co., Inc. 5.38%75.590.7%$1363.15m
ABBVAbbVie, Inc. 2.63%74.582.3%$1245.02m
BMYBristol-Myers Squibb Co. 3.43%54.601.0%$1099.14m
LLYEli Lilly & Co. 3.17%138.361.1%$924.81m
FTSVForty Seven, Inc. 0.88%95.380.0%$327.50m
NVSNovartis AG 2.59%81.330.2%$322.00m
GSKGlaxoSmithKline Plc 1.73%37.070.2%$281.42m
AZNAstraZeneca Plc 3.27%43.861.2%$277.11m
NVONovo Nordisk A/S 5.02%59.580.1%$175.22m
SNYSanofi 5.04%44.580.2%$166.32m
BHCBausch Health Cos., Inc. 0.07%14.520.0%$104.22m
RGENRepligen Corp. 3.39%95.697.1%$74.94m
RETAReata Pharmaceuticals, Inc. 2.81%154.213.4%$69.42m

Company Profile

Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by W. Christian Wigley, Waldemar Priebe, Philip J. Thomas, Jef Karel de Brabander, Thomas C. Südhof, Jonathan M. Graff and J. Warren Huff on September 1, 2002 and is headquartered in Irving, TX.